Immunotherapy for malignant lesions in man using immunogenic ribonucleic acid.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000276:immunology; D000818:Animals; D000970:Antineoplastic Agents / Q000276:immunology*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007167:Immunotherapy / Q000379:methods*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D009362:Neoplasm Metastasis; D012313:RNA / Q000276:immunology* / Q000627:therapeutic use; D012756:Sheep / Q000276:immunology
D000970:Antineoplastic Agents; D012313:RNA